Neuro Flashcards
1
Q
Bromocriptine
A
Parkinson
- **Dopamine agonist **
2
Q
Pramipexole
A
Parkinson
- **Dopamine agonist **
- ergot
3
Q
Ropinirole
A
Parkinson
- Dopamine agonist
- non ergot
4
Q
Amantadine
A
Parkinson
- **Increase dopamine release **
- Toxicity
- ataxia
- Also used as antiviral against influenza A and rubella
5
Q
L- Dopa
+
Carbidopa
A
Parkinson
- Increase dopamine
- L-dopa: converted to dopamine in CNS
- can cross BBB
- converted by dopa decarboxylase in CNS to dopamine
- Carbidopa: peripheral dopa decarboxylase inhibitor
- increases bioavailabilty of L-dopa in brain
- limits peripheral side effects
- no effect on CNS isde effect
- Toxicity
- arrhythmia- increased peripheral formation of catecholamines
- dyskinesia (following administration)
- akinesia (between doses)
- CNS
- anxiety, agitation, insomnia, confusion, delusions, hallucinations
- Do not give with vit B6
- increase coversion of l-dopa to dopamine in periphery
6
Q
Selegiline
A
Parkinson
- **Selective MAO- B inhibitor **
- preferentially metabolizes dopamine
- increasing availability of dopamine
- Clinical use
- adjuctive agent to L-dopa
- Toxicity
- may enhance adverse effects of L-dopa
7
Q
Entacapone
A
Parkinson
-
COMT inhibitor
- prevent L-dopa degradation
- increase dopamine availability
8
Q
Tolcapone
A
Parkinson
-
COMT inhibitors
- prevent L-dopa degradation
- increase levaopa availability
- hepatotoxicity
9
Q
Benztropine
A
Parkinson
- **Antimuscarinic **
- improves tremor, rigidity
- little effect on bradykinesia
- Use with drug induced parkinsonism from first generation antipsychotic
10
Q
Memantine
A
Alzheimer’s Disease
-
NMDA receptor antagonist
- prevent excitotoxicity
- mediated by Ca++
- Toxicity
- Dizziness
- Confusion
- Hallucinations
11
Q
Donepezil
A
Alzheimer’s
- **AChE Inhibitors **
- Toxicity
- nausea
- dizziness
- insomnia
12
Q
Galantamine
A
Alzheimer’s
- AChE inhibitors
- Toxicity
- nausea
- dizziness
- insomnia
13
Q
Rivastigmine
A
Alzheimer’s
- AChE inhibitors
- Toxicity
- nausea
- dizziness
- insomnia
14
Q
Tetrabenazine
A
Huntington’s
- Inhibit VMAT
- limit dopamine vesicle packaging and release
15
Q
Reserpine
A
Huntington
-
Inhibit VMAT
- limit dopamine vesicle packaging and release
16
Q
Haloperidol
A
Huntington
- **dopamine receptor antagonist **
17
Q
Sumatriptan
A
Migraine + Cluster Headaches
-
5-HT agonist
- inhibits trigeminal nerve activation
- prevents vasosctive peptide release (substance P + CGPR)
- induces vasoconstriction
- half life 2 hours
- Toxicity
- coronary vasospasm
- dont use in CAD or prinzmetal’s angina
- mild tingling
- coronary vasospasm
18
Q
Succinylcholine
A
Neuromuscular Blocking Drugs
- Muscle paralysis in surgery or mechanical ventilation
- Selective for motor nicotinic receptor
- Depolarizing
- Binds ACh receptor keeping it depolarized
- prevents muscle contraction
- Reversal of blockage
- phase 1: no antidote, block potentiated by cholinesteraes inhibitors
- phase 2: antidote = cholinesteraes inhibitors
- neostigmine
- Complications
- hypercalcemia
- hyperkalemia
- can lead to arrhythmias in peopel predisposed to hyperkalemia (burns, myopathies, crush injury, denervating injuries or disease)
- *malignant hyperthermia *